Monday, February 6, 2023
Google search engine
HomeMarketResultsCME Group Inc. (NASDAQ:CME) Increases Dividend to $4.50 Per Share

CME Group Inc. (NASDAQ:CME) Increases Dividend to $4.50 Per Share


CME Group Inc. (NASDAQ:CMEGet Rating) introduced a None dividend on Thursday, December eighth, Zacks studies. Stockholders of report on Wednesday, December twenty eighth will probably be paid a dividend of 4.50 per share by the monetary providers supplier on Wednesday, January 18th. The ex-dividend date is Tuesday, December twenty seventh. It is a enhance from CME Group’s earlier None dividend of $3.25.

CME Group has elevated its dividend by a median of 14.6% per 12 months during the last three years and has elevated its dividend yearly for the final 11 consecutive years. CME Group has a payout ratio of 48.0% that means its dividend is sufficiently coated by earnings. Analysts anticipate CME Group to earn $8.32 per share subsequent 12 months, which implies the corporate ought to proceed to have the ability to cowl its $4.00 annual dividend with an anticipated future payout ratio of 48.1%.

CME Group Worth Efficiency

Shares of CME Group stock opened at $173.33 on Monday. The agency has a market cap of $62.35 billion, a PE ratio of 23.58, a PEG ratio of two.79 and a beta of 0.40. The inventory has a 50 day shifting common of $174.14 and a 200 day shifting common of $188.47. The corporate has a present ratio of 1.02, a fast ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a 12 month low of $166.58 and a 12 month excessive of $256.94.

CME Group (NASDAQ:CMEGet Rating) final posted its earnings outcomes on Wednesday, October twenty sixth. The monetary providers supplier reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.05. CME Group had a return on fairness of 10.06% and a internet margin of 54.01%. The agency had income of $1.23 billion through the quarter, in comparison with the consensus estimate of $1.23 billion. On common, analysis analysts anticipate that CME Group will submit 7.98 EPS for the present fiscal 12 months.

Insider Shopping for and Promoting at CME Group

In associated information, Director William R. Shepard purchased 48,645 shares of the corporate’s inventory in a transaction on Friday, November 4th. The shares have been acquired at a median price of $170.00 per share, for a complete transaction of $8,269,650.00. Following the acquisition, the director now straight owns 247,843 shares of the corporate’s inventory, valued at $42,133,310. The acquisition was disclosed in a doc filed with the SEC, which is obtainable by means of the SEC website. 0.30% of the inventory is owned by company insiders.

Hedge Funds Weigh In On CME Group

Institutional traders have lately made adjustments to their positions within the firm. RB Capital Administration LLC raised its stake in CME Group by 11.4% within the first quarter. RB Capital Administration LLC now owns 1,419 shares of the monetary providers supplier’s inventory price $338,000 after shopping for a further 145 shares within the final quarter. Prudential PLC bought a brand new place in shares of CME Group within the 1st quarter price roughly $1,709,000. Cetera Funding Advisers raised its stake in shares of CME Group by 5.8% through the 1st quarter. Cetera Funding Advisers now owns 3,485 shares of the monetary providers supplier’s inventory price $829,000 after buying a further 190 shares within the final quarter. Sequoia Monetary Advisors LLC acquired a brand new stake in CME Group within the first quarter valued at roughly $281,000. Lastly, Candriam Luxembourg S.C.A. boosted its stake in CME Group by 9.5% within the first quarter. Candriam Luxembourg S.C.A. now owns 25,230 shares of the monetary providers supplier’s inventory valued at $6,001,000 after buying a further 2,181 shares within the final quarter. Hedge funds and different institutional traders personal 85.09% of the corporate’s inventory.

Wall Road Analysts Forecast Development

A variety of analysts have lately weighed in on the inventory. Rosenblatt Securities decreased their goal value on shares of CME Group from $171.00 to $161.00 and set a “promote” ranking on the inventory in a report on Wednesday, October fifth. Citigroup began protection on CME Group in a analysis report on Tuesday, October eleventh. They set a “purchase” ranking and a $220.00 value goal on the inventory. Credit score Suisse Group lowered their value goal on CME Group to $201.00 in a analysis notice on Monday, December twelfth. Morgan Stanley lower their goal value on CME Group from $213.00 to $208.00 and set an “equal weight” ranking on the inventory in a analysis report on Thursday, October twenty seventh. Lastly, Piper Sandler lowered their value goal on CME Group from $270.00 to $250.00 and set an “chubby” ranking for the corporate in a analysis report on Monday, December nineteenth. Two equities analysis analysts have rated the inventory with a promote ranking, seven have issued a maintain ranking and 7 have issued a purchase ranking to the inventory. In line with knowledge from MarketBeat, the inventory at present has a consensus ranking of “Maintain” and a consensus goal value of $225.00.

About CME Group

(Get Rating)

CME Group Inc, along with its subsidiaries, operates contract markets for the buying and selling of futures and choices on futures contracts worldwide. It gives futures and choices merchandise primarily based on rates of interest, fairness indexes, overseas alternate, agricultural commodities, power, and metals, in addition to fastened revenue merchandise.

Featured Tales

Dividend History for CME Group (NASDAQ:CME)

This instantaneous information alert was generated by narrative science know-how and monetary knowledge from MarketBeat with a view to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.

Earlier than you take into account CME Group, you may need to hear this.

MarketBeat retains monitor of Wall Road’s top-rated and greatest performing analysis analysts and the shares they suggest to their shoppers every day. MarketBeat has recognized the five stocks that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and CME Group wasn’t on the record.

Whereas CME Group at present has a “Maintain” ranking amongst analysts, top-rated analysts imagine these 5 shares are higher buys.

View The Five Stocks Here

Elon Musk’s Next Move

Questioning while you’ll lastly be capable to put money into SpaceX, StarLink or The Boring Firm? Click on the hyperlink under to be taught when Elon Musk will let these firms lastly IPO.

Get This Free Report

Elon Musk's Next Move Cover



Source link

RELATED ARTICLES
- Advertisment -
Google search engine

Most Popular

Recent Comments